Top Markets
Coin of the day
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Classificação em ações #16898
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Preço da ação
$2.46
Valor de mercado
$268.65M
Variação (1 dia)
-1.73%
Variação (1 ano)
-57.06%
País
CN
Negociar VISEN Pharmaceuticals (2561)

Categoria

Preço 2561 com a capitalização de mercado de B
VISEN Pharmaceuticals VISEN Pharmaceuticals
2561
$2.46
Capitalização de mercado de VISEN Pharmaceuticals(2561)
Valor de mercado: $268.65M
Em September 2026, VISEN Pharmaceuticals tem uma capitalização de mercado de $268.65M. Isso faz com que VISEN Pharmaceuticals seja a 16898th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de VISEN Pharmaceuticals de 2025 a 2026
2561 comparado com o topo de 5 mais populares stocks
Preço para 2561 Ativo B Capitalização de mercado de B Resultados
VISEN Pharmaceuticals VISEN Pharmaceuticals
$48,237.65 $268.65M
$5.260T +1,957,708.65%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$43,825.52 $268.65M
$4.779T +1,778,634.69%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$36,838.88 $268.65M
$4.017T +1,495,069.96%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$34,111.04 $268.65M
$3.719T +1,384,355.66%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$25,076.63 $268.65M
$2.734T +1,017,678.60%